Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2023 Aug 2;11(3):48.
doi: 10.3390/medsci11030048.

Effectiveness of Two Transcutaneous Electrical Nerve Stimulation (TENS) Protocols in Women with Provoked Vestibulodynia: A Randomized Controlled Trial

Affiliations
Randomized Controlled Trial

Effectiveness of Two Transcutaneous Electrical Nerve Stimulation (TENS) Protocols in Women with Provoked Vestibulodynia: A Randomized Controlled Trial

Filippo Murina et al. Med Sci (Basel). .

Abstract

Background: Vestibulodynia (VBD) is the most common form of vulvodynia. Because VBD is a pain disorder, transcutaneous electrical nerve stimulation (TENS) can be used as treatment. This study aims to evaluate the effects of two-parameter combinations (frequency and pulse duration) of TENS in reducing pain intensity and dyspareunia in VBD.

Methods: A randomized, double-blind, controlled trial was conducted to study the effect of two different electrical stimulation treatment regimens on women with VBD receiving domiciliary TENS. Outcomes were the mean change from baseline at 60 and 120 days of burning/pain and dyspareunia (VAS), Vulvar Pain Functional Questionnaire (V-Q), Female Sexual Functioning Index (FSFI) and vaginal electromyography measurements.

Results: A total of 78 subjects, 39 in each group, completed the trial. Patients in Groups 1 and 2 received a mean of 46.9 and 48.4 TENS sessions. By day 120, there was a 38.2% reduction in the burning/pain and a 52.1% reduction in the dyspareunia VAS scores in Group 1, as compared to 21.3% (p = 0.003) and 23.1% in Group 2 (p = 0.01), respectively. FSFI, V-Q, and muscle-strength measures also improved but were not statistically significant.

Conclusions: Our findings showed the potential of TENS in the treatment of VBD.

Keywords: TENS; dyspareunia; pelvic floor dysfunction; vestibulodynia; vulvar pain; vulvodynia.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Study flow chart.
Figure 2
Figure 2
Burning/pain and dyspareunia changes after 60 and 120 days of treatment.

Similar articles

Cited by

References

    1. Bornstein J., Goldstein A.T., Stockdale C.K., Bergeron S., Pukall C., Zolnoun D., Coady D., Goldstein A., Bachmann G.A., Bissonnette I., et al. 2015 ISSVD, ISSWSH, and IPPS consensus terminology and classification of persistent vulvar pain and vulvodynia. J. Sex. Med. 2016;13:607–612. doi: 10.1016/j.jsxm.2016.02.167. - DOI - PubMed
    1. Harlow B.L., Stewart E.G. A population-based assessment of chronic unexplained vulvar pain: Have we underestimated the prevalence of vulvodynia? J. Am. Med. Women’s Assoc. 2003;58:82–88. - PubMed
    1. Reed B.D., Harlow S.D., Sen A., Legocki L.J., Edwards R.M., Arato N., Haefner H.K. Prevalence and demographic characteristics of vulvodynia in a population-based sample. Am. J. Obstet. Gynecol. 2012;206:e1–e9. doi: 10.1016/j.ajog.2011.08.012. - DOI - PMC - PubMed
    1. Reed B.D., Legocki L.J., Plegue M.A., Sen A., Haefner H.K., Harlow S.D. Factors associated with vulvodynia incidence. Obstet. Gynecol. 2014;123:225–231. doi: 10.1097/AOG.0000000000000066. - DOI - PMC - PubMed
    1. Pukall C.F., Goldstein A.T., Bergeron S., Foster D., Stein A., Kellogg-Spadt S., Bachmann G. Vulvodynia: Definition, prevalence, impact, and pathophysiological factors. J. Sex. Med. 2016;13:291–304. doi: 10.1016/j.jsxm.2015.12.021. - DOI - PubMed

Publication types